Company intelligence / Profile preview

PharmEvidence

Ownership: Private
Employees: ~11
Development stage: Commercial

Overview

PharmEvidence SAS is a pharmaceutical company based in France, focused on pharmaceutical manufacturing and translational medicine. As of June 2025, there are no publicly disclosed drug candidates or clinical results. The company appears to be active in deals and translational medicine but does not have a visible product pipeline or published patents.

Industry: Drug Discovery Services

Beyond the preview

Go deeper on PharmEvidence.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on PharmEvidence.

Explore the full profile